Smesiglutide

In 2024, where are the prospects of innovative drugs？

The world's first TIL therapy is approved for marketing

Ginkgo: Total revenue in 2023 will be US$251 million, a decrease of 47%.The bio-pharmaceutical field will be the largest market in the future

US health insurance “cannot afford” $3 million in gene therapy

Gene therapy drugs